1 ANNEX, Regulation (EU) 2017/1510

In forcesince 30 Aug 2017

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

(1)

in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:

‘1,2-dichloropropane; propylene dichloride | 602-020-00-0 | 201-152-2 | 78-87-5 |

e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).] | 014-046-00-4 | — | —’ |

(2)

in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:

‘3,7-dimethylocta-2,6-dienenitrile | 608-067-00-3 | 225-918-0 | 5146-66-7’ |

(3)

in Appendix 5,

(a)

the following entries are inserted in the table in order of the index numbers set out therein:

‘brodifacoum (ISO);

4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin

607-172-00-1 | 259-980-5 | 56073-10-0 |

lead powder;

[particle diameter < 1 mm]

082-013-00-1 | 231-100-4 | 7439-92-1 |

lead massive:

[particle diameter ≥ 1 mm]

082-014-00-7 | 231-100-4 | 7439-92-1’ |

(b)

the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:

‘warfarin (ISO);

4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1]

(S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2]

(R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]

607-056-00-0 |

201-377-6 [1]

226-907-3 [2]

226-908-9 [3]

81-81-2 [1]

5543-57-7 [2]

5543-58-8 [3]’

(4)

in Appendix 6,

(a)

the following entries are inserted in the table in order of the index numbers set out therein:

‘tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol | 603-061-00-7 | 202-625-6 | 97-99-4 |

gallium arsenide | 031-001-00-4 | 215-114-8 | 1303-00-0 |

Tributyltin compounds, with the exception of those specified elsewhere in this Annex | 050-008-00-3 | — | — |

1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear | 607-710-00-5 | 271-093-5 | 68515-50-4 |

imidazole | 613-319-00-0 | 206-019-2 | 288-32-4 |

bisphenol A; 4,4′-isopropylidenediphenol | 604-030-00-0 | 201-245-8 | 80-05-7 |

phenol, dodecyl-, branched; [1]

phenol, 2-dodecyl-, branched; [2]

phenol, 3-dodecyl-, branched; [3]

phenol, 4-dodecyl-, branched; [4]

phenol, (tetrapropenyl) derivatives [5]

604-092-00-9 |

310-154-3 [1]

–

[2]

–

[3]

–

[4]

–

[5]

121158-58-5 [1]

–

[2]

–

[3]

210555-94-5 [4]

74499-35-7 [5]

chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione | 606-014-00-9 | 223-003-0 | 3691-35-8 |

coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin | 607-059-00-7 | 227-424-0 | 5836-29-3 |

difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin | 607-157-00-X | 259-978-4 | 56073-07-5 |

flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin | 607-375-00-5 | 421-960-0 | 90035-08-8 |

disodium octaborate anhydrous; [1]

disodium octaborate tetrahydrate [2]

005-020-00-3 |

234-541-0 [1]

234-541-0 [2]

12008-41-2 [1]

12280-03-4 [2]

bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one | 607-716-00-8 | 249-205-9 | 28772-56-7 |

difethialone (ISO);

3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one

607-717-00-3 | — | 104653-34-1 |

perfluorononan-1-oic acid [1]

and its sodium [2]

and ammonium [3] salts

607-718-00-9 |

206-801-3 [1]

–

[2]

–

[3]

375-95-1 [1]

21049-39-8 [2]

4149-60-4 [3]

dicyclohexyl phthalate | 607-719-00-4 | 201-545-9 | 84-61-7 |

triflumizole (ISO);

(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine

612-289-00-6 | — | 68694-11-1’ |

(b)

the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:

‘flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione | 613-166-00-X | — | 103361-09-7’ |